Suppr超能文献

CRISPR 基因组编辑技术在视网膜中的应用:脱靶效应的相关考量

CRISPR GENOME SURGERY IN THE RETINA IN LIGHT OF OFF-TARGETING.

机构信息

Institute of Human Nutrition, Columbia Stem Cell Initiative, College of Physicians and Surgeons, Columbia University, New York, New York.

Jonas Children's Vision Care, Bernard and Shirlee Brown Glaucoma Laboratory, New York, New York.

出版信息

Retina. 2018 Aug;38(8):1443-1455. doi: 10.1097/IAE.0000000000002197.

Abstract

PURPOSE

Recent concerns regarding the clinical utilization of clustered regularly interspaced short palindromic repeats (CRISPR) involve uncertainties about the potential detrimental effects that many arise due to unintended genetic changes, as in off-target mutagenesis, during CRISPR genome surgery. This review gives an overview of off-targeting detection methods and CRISPR's place in the clinical setting, specifically in the field of ophthalmology.

RESULTS

As CRISPR utilization in the laboratory setting has increased, knowledge regarding CRISPR mechanisms including its off-target effects has also increased. Although a perfect method for achieving 100% specificity is yet to be determined, the past few years have seen many developments in off-targeting detection and in increasing efficacy of CRISPR tools.

CONCLUSION

The CRISPR system has high potential to be an invaluable therapeutic tool as it has the ability to modify and repair pathogenic retinal lesions. Although it is not yet a perfect system, with further efforts to improve its specificity and efficacy along with careful screening of off-target mutations, CRISPR-mediated genome surgery potential can become maximized and applied to patients.

摘要

目的

最近人们对簇状规律间隔短回文重复序列(CRISPR)的临床应用产生了一些担忧,主要是因为在 CRISPR 基因组手术过程中,许多非预期的基因变化(如脱靶诱变)可能会产生潜在的有害影响。本综述概述了脱靶检测方法以及 CRISPR 在临床环境中的应用,特别是在眼科领域的应用。

结果

随着 CRISPR 在实验室中的应用不断增加,人们对 CRISPR 机制(包括其脱靶效应)的了解也不断增加。尽管尚未确定实现 100%特异性的完美方法,但在过去几年中,脱靶检测和提高 CRISPR 工具效率方面取得了许多进展。

结论

CRISPR 系统具有成为一种非常有价值的治疗工具的巨大潜力,因为它能够修饰和修复致病性视网膜病变。尽管它还不是一个完美的系统,但通过进一步努力提高其特异性和效率,并仔细筛选脱靶突变,CRISPR 介导的基因组手术潜力可以得到最大化,并应用于患者。

相似文献

2
Genome Editing in Retinal Diseases using CRISPR Technology.利用CRISPR技术进行视网膜疾病的基因组编辑
Ophthalmol Retina. 2018 Jan;2(1):1-3. doi: 10.1016/j.oret.2017.09.015. Epub 2017 Nov 7.
3
4
Tracking CRISPR's Footprints.追踪CRISPR的踪迹。
Methods Mol Biol. 2019;1961:13-28. doi: 10.1007/978-1-4939-9170-9_2.
6
CRISPR genome engineering for retinal diseases.CRISPR 基因组工程治疗视网膜疾病。
Prog Mol Biol Transl Sci. 2021;182:29-79. doi: 10.1016/bs.pmbts.2021.01.024. Epub 2021 Mar 19.
7
CRISPR/Cas9 genome surgery for retinal diseases.用于视网膜疾病的CRISPR/Cas9基因组手术。
Drug Discov Today Technol. 2018 Aug;28:23-32. doi: 10.1016/j.ddtec.2018.05.001. Epub 2018 Jun 18.

引用本文的文献

6
Genomics in medicine: A new era in medicine.医学中的基因组学:医学的新时代。
World J Methodol. 2021 Sep 20;11(5):231-242. doi: 10.5662/wjm.v11.i5.231.

本文引用的文献

1
Inter-homologue repair in fertilized human eggs?受精的人类卵子中的同源染色体间修复?
Nature. 2018 Aug;560(7717):E5-E7. doi: 10.1038/s41586-018-0379-5. Epub 2018 Aug 8.
4
Immunity to CRISPR Cas9 and Cas12a therapeutics.对 CRISPR Cas9 和 Cas12a 疗法的免疫。
Wiley Interdiscip Rev Syst Biol Med. 2018 Jan;10(1). doi: 10.1002/wsbm.1408. Epub 2017 Oct 30.
6
CRISPR-mediated Ophthalmic Genome Surgery.CRISPR介导的眼科基因组手术
Curr Ophthalmol Rep. 2017 Sep;5(3):199-206. doi: 10.1007/s40135-017-0144-1. Epub 2017 Jun 15.
9
Correction of a pathogenic gene mutation in human embryos.人类胚胎中致病基因突变的纠正。
Nature. 2017 Aug 24;548(7668):413-419. doi: 10.1038/nature23305. Epub 2017 Aug 2.
10
Disabling Cas9 by an anti-CRISPR DNA mimic.通过抗 CRISPR DNA 模拟物来使 Cas9 失活。
Sci Adv. 2017 Jul 12;3(7):e1701620. doi: 10.1126/sciadv.1701620. eCollection 2017 Jul.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验